Iliofemoral Deep Vein Thrombosis (DVT) affects 25% of all DVT cases, with a higher risk of post-thrombotic syndrome (PTS) and venous thromboembolism (VTE). Standard anticoagulation therapy often fails, leading to chronic pain, swelling, and venous ulcers.
Why Percutaneous Mechanical Thrombectomy (PMT)?
Compared to Catheter-Directed Thrombolysis (CDT), PMT offers:
- Lower PTS risk (PMT Villalta score: 2.1 vs. CDT: 5.1, P=0.03)
- Reduced bleeding complications (PMT: 0.2 units transfused vs. CDT: 1.2 units, P<0.05)
- Higher 6-month primary patency rates
What is the ClotTriever Catheter System?
The ClotTriever System (FDA & CE approved) is a minimally invasive mechanical thrombectomy device that removes clots without thrombolytics.
- Single-session thrombectomy
- Effectively removes acute & chronic thrombus
- Faster recovery, fewer complications
Clinical Evidence: CLOUT Registry Findings
A study of 250 patients showed:
- 99.6% treated in a single session
- 28-minute median thrombectomy time
- No thrombolytics required
Who Should Consider ClotTriever?
- Iliofemoral DVT patients
- High-risk PTS individuals
- Those contraindicated for thrombolytics
Conclusion
The ClotTriever Catheter System offers a safe, effective, and minimally invasive thrombectomy solution, reducing PTS and VTE risks while enhancing patient outcomes.
Content Details:-
Corresponding author: Michael Lichtenberg**
Full Length Article: Safety And Efficacy Analysis of The Clottriever CatheterSystem in Acute and Subacute Iliofemoral Deep VeinThrombosis Treatment
Journal: Austin Journal of Vascular Medicine
Disclaimer: This content is not owned or created by us. It has been sourced from the respective site, Austin Publishing Group, and is intended purely for study and educational purposes. All rights belong to the original authors and publishers.
No comments:
Post a Comment